Skip to content

Clinical trials

Phase 2 Overweight trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Phase: Phase 2 Country / region: Germany Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20111
20171
20191
20231
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Amgen1
Charite University, Berlin, Germany1
Cytoki Pharma1
Eli Lilly and Company1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
MedImmune LLC1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity9
Overweight9
Diabetes Mellitus, Type 24
Body Weight1
Diabetes Mellitus1
Hyperandrogenism1
Insulin Resistance1
Metabolic Diseases1
Nutrition Disorders1
Nutritional and Metabolic Diseases1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.